SALAMON RADIOLOGY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SALAMON RADIOLOGY
Largest movements
- Cash +€221,180
up €221,180 (+123%), from €180,057 to €401,237
mainly Net result for the year (+€251,951) and Current investments (+€70,926)
- Receivables within one year +€94,343
up €94,343 (+66.5%), from €141,785 to €236,129
of which Other amounts receivable: +€89,931
- Current investments -€70,926
down €70,926 (-39.6%), from €179,298 to €108,373
- Profit (loss) carried forward +€251,951
up €251,951 (+104%), from €242,965 to €494,916
- Gross operating margin +€8,340
up €8,340 (+2.6%), from €318,511 to €326,851
- Financial income +€4,452
up €4,452 (+301%), from €1,478 to €5,929
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €502,304 | €754,231 | +€251,927 | +50.2% |
| Fixed assets | 21/28 | €1,163 | €8,493 | +€7,329 | +630% |
| Tangible fixed assets | 22/27 | €1,163 | €8,493 | +€7,329 | +630% |
| Plant, machinery and equipment | 23 | - | €3,771 | +€3,771 | |
| Furniture and vehicles | 24 | €1,163 | €4,721 | +€3,558 | +306% |
| Current assets | 29/58 | €501,141 | €745,738 | +€244,597 | +48.8% |
| Amounts receivable within one year | 40/41 | €141,785 | €236,129 | +€94,343 | +66.5% |
| Trade receivables | 40 | €75,785 | €80,198 | +€4,413 | +5.8% |
| Other amounts receivable | 41 | €66,000 | €155,931 | +€89,931 | +136% |
| Current investments | 50/53 | €179,298 | €108,373 | -€70,926 | -39.6% |
| Cash at bank and in hand | 54/58 | €180,057 | €401,237 | +€221,180 | +123% |
| Total equity and liabilities | 10/49 | €502,304 | €754,231 | +€251,927 | +50.2% |
| Equity | 10/15 | €418,984 | €670,935 | +€251,951 | +60.1% |
| Contributions | 10/11 | €3,250 | €3,250 | = | 0.0% |
| Reserves | 13 | €172,769 | €172,769 | = | 0.0% |
| Distributable reserves | 133 | €172,769 | €172,769 | = | 0.0% |
| Profit (loss) carried forward | 14 | €242,965 | €494,916 | +€251,951 | +104% |
| Amounts payable | 17/49 | €83,320 | €83,296 | -€24 | 0.0% |
| Amounts payable within one year | 42/48 | €83,320 | €83,296 | -€24 | 0.0% |
| Trade debts | 44 | €968 | €1,301 | +€333 | +34.4% |
| Suppliers | 440/4 | €968 | €1,301 | +€333 | +34.4% |
| Taxes, remuneration and social security | 45 | €79,247 | €81,995 | +€2,748 | +3.5% |
| Taxes | 450/3 | €79,247 | €81,995 | +€2,748 | +3.5% |
| Other amounts payable | 47/48 | €3,105 | - | -€3,105 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €310 | €994 | +€684 | +220% |
| Other operating charges | 640/8 | €141 | €784 | +€643 | +458% |
| Gross operating margin | 9900 | €318,511 | €326,851 | +€8,340 | +2.6% |
| Operating profit (loss) | 9901 | €318,060 | €325,073 | +€7,013 | +2.2% |
| Financial income | 75/76B | €1,478 | €5,929 | +€4,452 | +301% |
| Recurring financial income | 75 | €1,478 | €5,929 | +€4,452 | +301% |
| Financial charges | 65/66B | €123 | €56 | -€67 | -54.3% |
| Recurring financial charges | 65 | €123 | €56 | -€67 | -54.3% |
| Profit (loss) for the period before taxes | 9903 | €319,415 | €330,946 | +€11,531 | +3.6% |
| Income taxes | 67/77 | €76,450 | €78,995 | +€2,545 | +3.3% |
| Profit (loss) for the period | 9904 | €242,965 | €251,951 | +€8,986 | +3.7% |
| Profit (loss) for the period to be appropriated | 9905 | €242,965 | €251,951 | +€8,986 | +3.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.